Tres Alchemix

At Tres Alchemix, we specialise in unraveling the complexity of the human body by harnessing the combined power of quantum-level chemical calculations and multi-omics AI. Our platforms provide highly accurate predictions of molecular behaviour, including chemical-protein interactions, pharmacokinetics and pharmacodynamics, offering unparalleled insights into the complex dynamics of drugs within the body. This cutting-edge technology forms the foundation of our way towards a holistic in silico human model, which will enable us to explore the root causes of various diseases and drive the development of novel therapeutics. Founded in 2023 in Fukuoka, Japan, we have since established our research and development hub in Oxford, UK. With a commitment to innovation and collaboration, our multidisciplinary team is consistently pushing the boundaries of pharmaceutical research.